Raju Prasad - 30 May 2025 Form 4 Insider Report for CRISPR Therapeutics AG (CRSP)

Role: Chief Financial Officer
Signature: /s/ Elizabeth Ryland Waldinger, attorney-in-fact
Issuer symbol: CRSP
Transactions as of: 30 May 2025
Net transactions value: $0
Form type: 4
Filing time: 03 Jun 2025, 21:45:05 UTC
Previous filing: 24 Mar 2025
Next filing: 03 Oct 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Prasad Raju	Chief Financial Officer	C/O CRISPR THERAPEUTICS, 105 WEST FIRST STREET, BOSTON	/s/ Elizabeth Ryland Waldinger, attorney-in-fact	03 Jun 2025	0001968317

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRSP	Restricted Stock Units	Award	$0	+20,000		$0.000000	20,000	30 May 2025	Common Shares	20,000		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
F2	This restricted stock unit award was granted on May 30, 2025 with respect to 20,000 Common Shares, with 100% of the shares vesting on May 30, 2028.